ClinicalTrials.Veeva

Menu

Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope (VISUAL)

H

HaEmek Medical Center, Israel

Status

Unknown

Conditions

Respiratory Distress Syndrome

Treatments

Device: using specially adapted VNscope
Drug: surfactant administration

Study type

Interventional

Funder types

Other

Identifiers

NCT03846960
0149-18-EMC

Details and patient eligibility

About

In this study the investigators intend to assess the feasibility of surfactant administration via a thin catheter using a specially adapted video laryngoscope, with a groove designed to allow insertion of an endovascular catheter without the use of other instruments in the oral cavity (forceps ect.). The laryngoscope is of Peak Medic Ltd, Netania, Israel.

Full description

A prospective study to assess the safety and efficacy of surfactant administration via thin catheter using a specially adapted VNscope, originally used for endotracheal intubation and adapted for the administration of surfactant without the placement of an endotracheal tube.

Once neonates present respiratory distress, the adapted scope will be used - clinical and outcome measures will be collected to asses the safety and efficacy of the use

Enrollment

20 estimated patients

Sex

All

Ages

30 to 36 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Premature infants with gestational age 30-36 weeks.
    • Diagnosis of respiratory distress syndrome
    • Treatment with antenatal steroids.
    • Spontaneously breathing with non-invasive positive pressure ventilation.
    • maximal age 3 days.

Exclusion criteria

    • Apgar score at 5 min < 5
    • Need for chest compressions or medication upon delivery.
    • Evident major congenital malformation, metabolic or genetic disorders.
    • Clinical evidence of sepsis.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

preterm infants
Experimental group
Description:
A prospective study to assess the safety and efficacy of surfactant administration via thin catheter using a specially adapted VNscope, originally used for endotracheal intubation and adapted for the administration of surfactant without the placement of an endotracheal tube. A feasibility study of 10 preterm infants 30-36 gestational age at birth, that requires surfactant administration for the indication of respiratory distress syndrome, and do not require immediate intubation
Treatment:
Drug: surfactant administration
Device: using specially adapted VNscope

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems